NYSE Content Update: Goldman Sachs Asset Management Launches Two New ETFs

NYSE issues a pre-market daily advisory direct from the trading floor. NEW…

LEIFRAS Awarded Tobishima Village's Weekend School Club Activities Contract for the Third Consecutive Year — Fostering Non-Cognitive Skills Through Instruction by Full-Time Staff

Fulfilling Work-Style Reforms for Teachers While Ensuring a Safe, High-Quality Sports Environment…

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.81 Million Tokens, and Total Crypto and Total Cash Holdings of $11.6 Billion

Bitmine owns 4.8% of the total ETH coin supply of 120.7 million Bitmine…

POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine

GUANGZHOU, China, Aug. 10, 2026 /PRNewswire/ — POMDOCTOR LIMITED ("Pomdoctor" or the…

ThinkPalm and Singapore Polytechnic Advance Sustainable IIoT for SMEs and Start-Ups

SINGAPORE, Aug. 10, 2026 /PRNewswire/ — ThinkPalm Technologies, a technology solutions provider…

The Ultimate Wellness Getaway in Vietnam's UNESCO World Heritage Site

HALONG, Vietnam, Aug. 10, 2026 /PRNewswire/ — Bhaya Cruises, the leading cruise…

Two CityUHK scholars elected to the European Academy of Engineering in recognition of their internationally acclaimed research achievements

HONG KONG, Aug. 10, 2026 /PRNewswire/ — Professor Li Wen Jung, Vice-President…

Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35

-ASC36_35FDC, a once-monthly subcutaneous (SQ) fixed dose combination (FDC) injection of ASC36…